A team of German scientists has developed a new compound that dramatically decreases the damage to neurons in rats exhibiting stroke symptoms.

The research findings are published in the May 26 issue of the Journal of Biological Chemistry. The findings say the immunosuppressive drug FK506 (also known as Tacrolimus or Prograf) that is often given to patients receiving transplants to prevent organ rejection has far reaching medical applications

A study of residential areas in St. Louis uncovers some startling results about healthcare and the elderly.

Middle-aged and older African-Americans who live in rundown neighborhoods with poor air and street quality are three times more likely to develop difficulties walking, standing, or lifting than those in cleaner, better-maintained areas

A new study suggests that rheumatoid arthritis treatments are not causing an increased risk of lymphoma.

Instead, the Swedish researchers found that chronic inflammation, one of the symptoms of the illness, is responsible. HealthDay News reports that as the arthritis worsens, the cancer risk goes up

A scientific statement from the American Heart Association/American Stroke Association says that the primary risk for those who have had a stroke, even a mini-stroke, is a second attack.

Strokes and mini-strokes, officially called a "transient ischemic attack," were thought to be best treated separately. However, this new information makes a shift from that earlier theory

A new report shows that a staggering eight million children world-wide are born with a serious genetic birth defect each year.

The March of Dimes health agency conducted the first comprehensive global analysis of the problem